(Q37612522)

21 August 2017

Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12. (English)

1 reference

21 August 2017

0 references

0 references

0 references

Rongxiu Zheng

1

1 reference

21 August 2017

Peter A Cohen

2

1 reference

21 August 2017

Christopher A Paustian

3

1 reference

21 August 2017

Terrence D Johnson

4

1 reference

21 August 2017

Walter T Lee

5

1 reference

21 August 2017

Suyu Shu

6

1 reference

21 August 2017

Gary K Koski

7

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

21 August 2017

1 reference

21 August 2017

68

1 reference

21 August 2017

11

1 reference

21 August 2017

4045-4049

1 reference

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Innate immunity: the virtues of a nonclonal system of recognition

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Signal 3 tolerant CD8 T cells degranulate in response to antigen but lack granzyme B to mediate cytolysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Therapeutic immune response induced by electrofusion of dendritic and tumor cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939830

Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion

1 September 2018

1 reference

12 December 2020

Tumor-dendritic cell fusion technology and immunotherapy strategies

1 reference

12 December 2020

Adoptive immunotherapy of newly induced murine sarcomas

1 reference

12 December 2020

Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells

1 reference

12 December 2020

Toll-like receptors: linking innate and adaptive immunity

1 reference

12 December 2020

10.1158/0008-5472.CAN-07-6669

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

18519662

1 reference